Your browser doesn't support javascript.
loading
Rate of speech decline in individuals with amyotrophic lateral sclerosis.
Eshghi, Marziye; Yunusova, Yana; Connaghan, Kathryn P; Perry, Bridget J; Maffei, Marc F; Berry, James D; Zinman, Lorne; Kalra, Sanjay; Korngut, Lawrence; Genge, Angela; Dionne, Annie; Green, Jordan R.
Affiliation
  • Eshghi M; Depatment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA.
  • Yunusova Y; Department of Radiology, The Athinoula A. Martinos Center for Biomedical Images, MGH, Harvard Medical School, Boston, MA, USA.
  • Connaghan KP; Department of Speech-Language Pathology, Rehabilitation Sciences Institute, University of Toronto, Toronto, ON, Canada.
  • Perry BJ; Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.
  • Maffei MF; KITE -Toronto Rehabilitation Institute - University Health Network, Toronto, ON, Canada.
  • Berry JD; Depatment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA.
  • Zinman L; Depatment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA.
  • Kalra S; Depatment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA.
  • Korngut L; Department of Neurology, Sean M. Healey and AMG Center for ALS, MGH, Boston, USA.
  • Genge A; Division of Neurology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Dionne A; Sunnybrook Health Sciences Centre, Toronto, Canada.
  • Green JR; Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Sci Rep ; 12(1): 15713, 2022 09 20.
Article in En | MEDLINE | ID: mdl-36127362
ABSTRACT
Although speech declines rapidly in some individuals with amyotrophic lateral sclerosis (ALS), longitudinal changes in speech have rarely been characterized. The study objectives were to model the rate of decline in speaking rate and speech intelligibility as a function of disease onset site, sex, and age at onset in 166 individuals with ALS; and estimate time to speech loss from symptom onset. We also examined the association between clinical (speaking rate/intelligibility) measures and patient-reported measures of ALS progression (ALSFRS-R). Speech measures declined faster in the bulbar-onset group than in the spinal-onset group. The rate of decline was not significantly affected by sex and age. Functional speech was still maintained at 60 months since disease onset for most patients with spinal onset. However, the time to speech loss was 23 months based on speaking rate < 120 (w/m) and 32 months based on speech intelligibility < 85% in individuals with ALS-bulbar onset. Speech measures were more responsive to functional decline than were the patient-reported measures. The findings of this study will inform future work directed toward improving speech prognosis in ALS, which is critical for determining the appropriate timing of interventions, providing appropriate counseling for patients, and evaluating functional changes during clinical trials.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amyotrophic Lateral Sclerosis Type of study: Etiology_studies / Prognostic_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: United States